Common Contracts
2 similar Sublicense and Development Agreement contracts by Dov Pharmaceutical Inc, Neurocrine Biosciences Inc
AMENDMENTSublicense and Development Agreement • March 31st, 2008 • Dov Pharmaceutical Inc • Pharmaceutical preparations • New York
AMENDMENT dated October 29, 2007 to the Sublicense and Development Agreement dated June 30, 1998 (the “Sublicense Agreement”) by and between DOV Pharmaceutical, Inc. 150 Pierce St., Somerset, NJ 08873 (“DOV”) and Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130 (“Neurocrine”).
AMENDMENTSublicense and Development Agreement • February 11th, 2008 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
AMENDMENT dated October 29, 2007 to the Sublicense and Development Agreement dated June 30, 1998 (the “Sublicense Agreement”) by and between DOV Pharmaceutical, Inc. 150 Pierce St., Somerset, NJ 08873 (“DOV”) and Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130 (“Neurocrine”).
